ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christopher M.R. Satur
David J. Wheatley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Satur, C. M.R.
Right arrow Articles by Wheatley, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satur, C. M.R.
Right arrow Articles by Wheatley, D. J.

Ann Thorac Surg 1999;68:2225-2230
© 1999 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Can technetium 99m pyrophosphate be used to quantify myocardial injury in donor hearts?

Christopher M.R. Satur, FRCS, David Doyle, MD, Sally Darracott-Cankovic, PhD, William Martin, PhD, David J. Wheatley, FRCS

a Department of Cardiothoracic Surgery and Nuclear Cardiology, Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom

Address reprint requests to Dr Satur, Department of Cardiac Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK

Background. There are no prospective methods available to quantify the myocyte injury in hearts prior to transplantation. The potential of the isotope labeled infarct marker 99m Technetium pyrophosphate (TcPPT) being used in this role was investigated.

Methods. Brain death was induced by creating an extradural space occupying lesion in young adult swine after which hemodynamic changes were monitored and myocyte injury was quantified by histochemistry. TcPPT was administered 5 hours after induction of intracranial hypertension, and after hearts were harvested myocardial uptake was measured. These latter measurements were related to the histochemical assessment of myocyte injury.

Results. Sham animals (n = 4) maintained cardiovascular stability and experienced minimal myocyte injury, grades 0 to 3. BD animals (n = 10) exhibited varying patterns of hemodynamic change and myocyte injury, the latter was significant in 6, graded 4 to 11, p less than 0.05. Uptake of TcPPT by BD hearts was greater than twice the 90th centile sham value in 6. The sensitivity and specificity of greater uptake indicating the presence of myocyte injury was 83.3% and 75% respectively.

Conclusions. TcPPT has the potential to quantify myocardial injury induced by brain death and its potential utility merits further investigation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.